Citation: Li-Ping Lin, Fei-Hua Wu, Jing-Yu Liang. The first examples of ilexgenin A hybrids as a new class of multi-potent, anti-platelet agents[J]. Chinese Chemical Letters, ;2013, 24(8): 723-726. shu

The first examples of ilexgenin A hybrids as a new class of multi-potent, anti-platelet agents

  • Corresponding author: Fei-Hua Wu,  Jing-Yu Liang, 
  • Received Date: 13 April 2013
    Available Online: 6 May 2013

  • Seventeen novel ilexgenin A hybrids (IA-aspirin) and (IA-NO), as donor hybrids (IA-NO will release NO in vivo and function as NO donor), were designed and synthesized in order to develop new multi-targeting agents for the treatment of platelet disorders. Their in vitro activities against ADP, AA and thrombin were evaluated. As a result, IA hybrids achieved substantial increases in the three tested pathways compared with IA. Encouragingly, the most potent hybrid compounds 6d and 14d displayed about 8-fold higher potency than aspirin, and 3-fold higher potency than the simultaneous administration of aspirin and IA in inhibiting ADP-induced aggregation with IC50 values of 0.15 mmol/L and 0.14 mmol/L, respectively. The results suggest these IA hybrids are good candidates for multi-target therapies, and especially, may be considered as promising ADP agonists.
  • 加载中
    1. [1]

      [1] S. Yusuf, S. Reddy, S. Ounpuu, S. Anand, Global burden of cardiovascular diseases. Part I: General considerations, the epidemiologic transition, risk factors, and impact of urbanization, Circulation 104 (2001) 2746-2753.

    2. [2]

      [2] M.J. Davies, A.C. Thomas, Plaque fissuring -the cause of acutemyocardial infarction, sudden ischaemic death and crescendo angina, Br. Heart J. 53 (1985) 363-373.

    3. [3]

      [3] V. Fuster, L. Badimon, J.J. Badimon, J.H. Chesebro, The pathogenesis of coronary artery disease and the acute coronary syndromes, N. Engl. J. Med. 326 (1992) 242-250.

    4. [4]

      [4] H. Yang, G.Y. Hu, J. Chen, Y. Wang, Z.H. Wang, Synthesis, resolution, and antiplatelet activity of 3-substituted 1(3H)-isobenzofuranone, Bioorg. Med. Chem. Lett. 17 (2007) 5210-5213.

    5. [5]

      [5] L.A. Urbano, J. Bogousslavsky, Antiplatelet drugs in ischemic stroke prevention: from monotherapy to treatment, Cerebrovasc. Dis. 17 (2004) 74-80.

    6. [6]

      [6] G. Micieli, A. Cavallini, New therapeutic strategies with antiplatelet agents, Neurol. Sci. 25 (2004) S13-S15.

    7. [7]

      [7] (a) Y.N. Han, S.K. Baik, T.H. Kim, B.H. Han, Antithrombotic activities of saponins from Ilex pubescens, Arch. Pharm. Res. 10 (1987) 115-120;

    8. [8]

      (b) D.K. Lee, H.S. Lee, M.D. Huh, et al., Antiplatelet action of Ilexoside D, a triterpenoid saponin from Ilex pubescens, Arch. Pharm. Res. 14 (1991) 352-356;

    9. [9]

      (c) Y.N. Han, J.I. Song, I.K. Rhee, Anticoagulant activity of Ilexoside D, a triterpenoid saponin from Ilex pubescens, Arch. Pharm. Res. 16 (1993) 209-212.

    10. [10]

      [8] B.Q. Li, N.G. Li, F. Feng, Y.P. Tang, J.A. Duan, Synthesis and anti-platelet aggregation activities of ferulic acid esters, J. China Pharm. Univ. 40 (2009) 486-490.

    11. [11]

      [9] (a) Y. Li, X.L. Wang, R. Fu, et al., Synthesis and evaluation of nitric oxide-releasing derivatives of 3-n-butylphthalide as anti-platelet agents, Bioorg. Med. Chem. Lett. 21 (2011) 4210-4214;

    12. [12]

      (b) Z.L. Min, Y.H. Zhang, P. Zhuang, et al., Synthesis and anti-platelet activities of nitric-oxide releasing derivatives of 3-butylphthalide, J. China Pharm. Univ. 39 (2008) 392-397.

    13. [13]

      [10] C. Patrono, B. Coller, J.E. Dalen, Platelet-active drugs: the relationships among dose, effectiveness, and side effects, Chest 119 (Suppl. 1) (2001) 39S-63S.

    14. [14]

      [11] P.G. Wang, M. Xian, X.P. Tang, et al., Nitric oxide donors: chemical activities and biological applications, Chem. Rev. 102 (2002) 1091-1134.

    15. [15]

      [12] G.V.R. Born, M.J. Cross, The aggregation of blood platelets, J. Physiol. 168 (1963) 178-195.

    16. [16]

      [13] Antiplatelet aggregation assays: Blood samples were withdrawn from rat abdominal aorta and mixed with 3.8% trisodium citrate (9:1, v/v), followed by centrifuging at 1000 rpm for 10 min. The supernatants were collected and used as platelet rich plasma (PRP). Additional sample were centrifuged at 3000 rpm for 10 min and the supernatants were collected as platelet poor plasma (PPP). The effect of individual compounds on the AA, ADP and thrombin-induced platelet aggregation was measured by the Born's turbidimetric method using a Platelet-Aggregometer (LBY-NJ Platelet-Aggregometer, Beijing). Briefly, PRP (280 mL) was pre-treated in duplicated with vehicle (0.5% DMSO), different concentrations of individual compounds or the reference drugs and exposed to 10 mL of AA (final concentration 40 μmol/L), ADP (final concentration 10 μmol/L) or thrombin (final concentration 5 U/mL) incubated at 37 ℃ for 5 min. Changes in the light transmittance of the reaction mixture were continuously recorded for 5 min and the maximal aggregation was also recorded. The anti-platelet aggregation activity of tested compound was evaluated as inhibition rate (%) which was determined using the following formula: Inhibition rate (%) = (1 the maximal aggregation of compound/the maximal aggregation of control)×100.

    17. [17]

      [14] P. Theroux, Antiplatelet therapy: do the new platelet inhibitors add significantly to the clinical benefits of aspirin? Am. Heart J. 134 (1997) s62-s70.

    18. [18]

      [15] J.B. Li, Z. Jian, L. Huang, et al., Comparison of collagen vs adenosine diphosphate in detecting antiplatelet effect in patients with coronary artery disease, Biomed. Pharm. 63 (2009) 608-612.

  • 加载中
    1. [1]

      Tao LongPeng ChenBin FengCaili YangKairong WangYulei WangCan ChenYaping WangRuotong LiMeng WuMinhuan LanWei Kong PangJian-Fang WuYuan-Li Ding . Reinforced concrete-like Na3.5V1.5Mn0.5(PO4)3@graphene hybrids with hierarchical porosity as durable and high-rate sodium-ion battery cathode. Chinese Chemical Letters, 2024, 35(4): 109267-. doi: 10.1016/j.cclet.2023.109267

    2. [2]

      Xue-Jiao WangJun-Li XinHong XiangZe-Yu ZhaoYu-Hang HeHaibo WangGuangyao MeiYi-Cheng MaoJuan XiongJin-Feng Hu . Holotrichones A and B, potent anti-leukemic lindenane-type sesquiterpene trimers with unprecedented complex carbon skeletons from a rare Chloranthus species. Chinese Chemical Letters, 2024, 35(12): 109682-. doi: 10.1016/j.cclet.2024.109682

    3. [3]

      Jian SongShenghui WangQiuge LiuXiao WangShuo YuanHongmin LiuSaiyang ZhangN-Benzyl arylamide derivatives as novel and potent tubulin polymerization inhibitors against gastric cancers: Design, structure–activity relationships and biological evaluations. Chinese Chemical Letters, 2025, 36(2): 109678-. doi: 10.1016/j.cclet.2024.109678

    4. [4]

      Haiyang Gu Xiang Xu . Multicolor hybrid metal halides and anti-counterfeiting. Chinese Journal of Structural Chemistry, 2024, 43(9): 100352-100352. doi: 10.1016/j.cjsc.2024.100352

    5. [5]

      Xingyu ChenSihui ZhuangWeiyao YanZhengli ZengJianguo FengHongen CaoLei Yu . Synthesis, antibacterial evaluation, and safety assessment of Se@PLA as a potent bactericide against Xanthomonas oryzae pv. oryzae. Chinese Chemical Letters, 2024, 35(10): 109635-. doi: 10.1016/j.cclet.2024.109635

    6. [6]

      Mianling YangMeehyein KimPeng Zhan . Modular miniaturized synthesis and in situ biological evaluation facilitate rapid discovery of potent MraY inhibitors as antibacterial agents. Chinese Chemical Letters, 2025, 36(2): 110455-. doi: 10.1016/j.cclet.2024.110455

    7. [7]

      Wenhao YanShuaiya XueXuerui ZhaoWei ZhangJian Li . Hexagonal boron nitride based slippery liquid infused porous surface with anti-corrosion, anti-contaminant and anti-icing properties for protecting magnesium alloy. Chinese Chemical Letters, 2024, 35(4): 109224-. doi: 10.1016/j.cclet.2023.109224

    8. [8]

      Guangyao WangZhitong XuYe QiYueguang FangGuiling NingJunwei Ye . Electrospun nanofibrous membranes with antimicrobial activity for air filtration. Chinese Chemical Letters, 2024, 35(10): 109503-. doi: 10.1016/j.cclet.2024.109503

    9. [9]

      Kebo XieQian ZhangFei YeJungui Dai . A multi-enzymatic cascade reaction for the synthesis of bioactive C-oligosaccharides. Chinese Chemical Letters, 2024, 35(6): 109028-. doi: 10.1016/j.cclet.2023.109028

    10. [10]

      Ting WangXin YuYaqiang Xie . Unlocking stability: Preserving activity of biomimetic catalysts with covalent organic framework cladding. Chinese Chemical Letters, 2024, 35(6): 109320-. doi: 10.1016/j.cclet.2023.109320

    11. [11]

      Fangping YangJin ShiYuansong WeiQing GaoJingrui ShenLichen YinHaoyu Tang . Mixed-charge glycopolypeptides as antibacterial coatings with long-term activity. Chinese Chemical Letters, 2025, 36(2): 109746-. doi: 10.1016/j.cclet.2024.109746

    12. [12]

      Chong LiuLing LiJiahui GaoYanwei LiNazhen ZhangJing ZangCong LiuZhaopei GuoYanhui LiHuayu Tian . The study of antibacterial activity of cationic poly(β-amino ester) regulating by amphiphilic balance. Chinese Chemical Letters, 2025, 36(2): 110118-. doi: 10.1016/j.cclet.2024.110118

    13. [13]

      Ruikui YANXiaoli CHENMiao CAIJing RENHuali CUIHua YANGJijiang WANG . Design, synthesis, and fluorescence sensing performance of highly sensitive and multi-response lanthanide metal-organic frameworks. Chinese Journal of Inorganic Chemistry, 2024, 40(4): 834-848. doi: 10.11862/CJIC.20230301

    14. [14]

      Kun Zhang Ni Dan Dan-Dan Ren Ruo-Yu Zhang Xiaoyan Lu Ya-Pan Wu Li-Lei Zhang Hong-Ru Fu Dong-Sheng Li . A small D-A molecule with highly heat-resisting room temperature phosphorescence for white emission and anti-counterfeiting. Chinese Journal of Structural Chemistry, 2024, 43(3): 100244-100244. doi: 10.1016/j.cjsc.2024.100244

    15. [15]

      Qiang LiJiangbo FanHongkai MuLin ChenYongzhen YangShiping Yu . Nucleus-targeting orange-emissive carbon dots delivery adriamycin for enhanced anti-liver cancer therapy. Chinese Chemical Letters, 2024, 35(6): 108947-. doi: 10.1016/j.cclet.2023.108947

    16. [16]

      Ji ZhangTong ZhangQiao AnPeng ZhangCai-Yan TianChun-Mao YuanPing YiZhan-Xing HuXiao-Jiang Hao . Five quinolizidine alkaloids with anti-tobacco mosaic virus activities from two species of Sophora. Chinese Chemical Letters, 2024, 35(6): 108927-. doi: 10.1016/j.cclet.2023.108927

    17. [17]

      Huaran ZhangYuting HuangYingjie TangDekun KongYi Zou . Genome mining of multi-substituted alkylresorcinols from a hybrid highly reducing- and type Ⅲ- polyketide pathway. Chinese Chemical Letters, 2024, 35(7): 108968-. doi: 10.1016/j.cclet.2023.108968

    18. [18]

      Xiaoning LiQuanyu ShiMeng LiNingxin SongYumeng XiaoHuining XiaoTony D. JamesLei Feng . Functionalization of cellulose carbon dots with different elements (N, B and S) for mercury ion detection and anti-counterfeit applications. Chinese Chemical Letters, 2024, 35(7): 109021-. doi: 10.1016/j.cclet.2023.109021

    19. [19]

      Wenyu GaoLiming ZhangChuang ZhaoLixiang LiuXingran YangJinbo Zhao . Controlled semi-Pinacol rearrangement on a strained ring: Efficient access to multi-substituted cyclopropanes by group migration strategy. Chinese Chemical Letters, 2024, 35(9): 109447-. doi: 10.1016/j.cclet.2023.109447

    20. [20]

      Bohan ZhangBingzhe WangGuichuan XingZikang TangSongnan Qu . Regulation of the multi-emission centers in carbon dots via a bottom-up synthesis approach. Chinese Chemical Letters, 2024, 35(9): 109358-. doi: 10.1016/j.cclet.2023.109358

Metrics
  • PDF Downloads(0)
  • Abstract views(632)
  • HTML views(9)

通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Address:Zhongguancun North First Street 2,100190 Beijing, PR China Tel: +86-010-82449177-888
Powered By info@rhhz.net

/

DownLoad:  Full-Size Img  PowerPoint
Return